Nucala
- Product NDC
- 0173-0904
- 11-digit product format
- 001730904
- Labeler code
- 0173
- Product ID
- 0173-0904_869b75ba-b2a0-406e-9ed2-136b75763d78
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- mepolizumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- GlaxoSmithKline LLC
- Application
- BLA761122
- Marketing category
- BLA
- Marketing start
- 2022-01-22
- Substance
- MEPOLIZUMAB
- Active strength
- 40 mg/.4mL
- Pharmacologic classes
- Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nucala
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MEPOLIZUMAB | 40 mg/.4mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 90Z2UF0E52 |
| Rxcui | 1720601, 1720606, 2170990, 2170993, 2173820, 2173822, 2596444, 2596445 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5ba65d73-eb90-46f2-816e-82ee2be9e649 | Product name | 2 | 20190910 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0173-0904-42 | Nucala | 0.4 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.4 | 24 | |
| 0173-0904-42 | Nucala | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 24 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0173-0904-42 | ML - Milliliter | 0173-0904 | 98e57eaf-c8db-4b6a-9772-e1f396ef43d8 | 1 | 2022-08-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MEPOLIZUMAB | ACTIVE INGREDIENT | 90Z2UF0E52 | NUCALA (MEPOLIZUMAB) INJECTION, POWDER, FOR SOLUTION [GLAXOSMITHKLINE LLC] | 2 | |
| MEPOLIZUMAB | ACTIVE MOIETY | 90Z2UF0E52 | NUCALA (MEPOLIZUMAB) INJECTION, POWDER, FOR SOLUTION [GLAXOSMITHKLINE LLC] | 2 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | NUCALA (MEPOLIZUMAB) INJECTION, POWDER, FOR SOLUTION [GLAXOSMITHKLINE LLC] | 2 | |
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INACTIVE INGREDIENT | 70WT22SF4B | NUCALA (MEPOLIZUMAB) INJECTION, POWDER, FOR SOLUTION [GLAXOSMITHKLINE LLC] | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | NUCALA (MEPOLIZUMAB) INJECTION, POWDER, FOR SOLUTION [GLAXOSMITHKLINE LLC] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0173-0904 | NUCALA (MEPOLIZUMAB) INJECTION, POWDER, FOR SOLUTION NUCALA (MEPOLIZUMAB) INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | 22 | Current NDC, Legacy NDC, 2 package rows | 20250524_fefb887c-e4ac-431e-8893-e9d1a5a63fea.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2170990 | mepolizumab 100 MG in 1 mL Auto-Injector | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2173820 | mepolizumab 100 MG in 1 mL Prefilled Syringe | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 1720601 | mepolizumab 100 MG Injection | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2596444 | mepolizumab 40 MG in 0.4 ML Prefilled Syringe | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2170993 | Nucala 100 MG in 1 mL Auto-Injector | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2173822 | Nucala 100 MG in 1 mL Prefilled Syringe | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 1720606 | Nucala 100 MG Injection | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2596445 | Nucala 40 MG in 0.4 ML Prefilled Syringe | PSN | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2596445 | 0.4 ML mepolizumab 100 MG/ML Prefilled Syringe [Nucala] | SBD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2170993 | 1 ML mepolizumab 100 MG/ML Auto-Injector [Nucala] | SBD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2173822 | 1 ML mepolizumab 100 MG/ML Prefilled Syringe [Nucala] | SBD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 1720606 | mepolizumab 100 MG Injection [Nucala] | SBD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2596444 | 0.4 ML mepolizumab 100 MG/ML Prefilled Syringe | SCD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2170990 | 1 ML mepolizumab 100 MG/ML Auto-Injector | SCD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2173820 | 1 ML mepolizumab 100 MG/ML Prefilled Syringe | SCD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 1720601 | mepolizumab 100 MG Injection | SCD | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2596445 | 0.4 ML Nucala 100 MG/ML Prefilled Syringe | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2170993 | 1 ML Nucala 100 MG/ML Auto-Injector | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2173822 | 1 ML Nucala 100 MG/ML Prefilled Syringe | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2170990 | mepolizumab 100 MG per 1 ML Auto-Injector | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2173820 | mepolizumab 100 MG per 1 ML Prefilled Syringe | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2596444 | mepolizumab 40 MG per 0.4 ML Prefilled Syringe | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 1720606 | Nucala 100 MG Injection | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2170993 | Nucala 100 MG per 1 ML Auto-Injector | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2173822 | Nucala 100 MG per 1 ML Prefilled Syringe | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
| 2596445 | Nucala 40 MG per 0.4 ML Prefilled Syringe | SY | fefb887c-e4ac-431e-8893-e9d1a5a63fea | 24 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0173-0904-42 | 00173090442 | 1 SYRINGE in 1 CARTON (0173-0904-42) / .4 mL in 1 SYRINGE | 1 syringe | 2022-01-22 | 0000-00-00 | No | No | Current |